BROOKS Intraday Analysis...

BROOKS Share Price

Open 105.85 Change Price %
High 105.85 1 Day -1.50 -1.44
Low 101.10 1 Week -5.65 -5.22
Close 102.50 1 Month -9.95 -8.85
Volume 28907 1 Year 21.50 26.54
52 Week High 194.70
52 Week Low 81.20
BROOKS Important Levels
Resistance 2 106.90
Resistance 1 105.09
Pivot 103.15
Support 1 99.91
Support 2 98.10
NSE INDIA Most Active Stocks
JPASSOCIAT 20.05 -4.52%
GMRINFRA 19.30 0.26%
UNITECH 5.90 9.26%
RCOM 20.85 -3.92%
SUZLON 17.65 -2.49%
JPINFRATEC 16.60 11.41%
JPPOWER 5.25 -2.78%
3IINFOTECH 4.55 12.35%
IBREALEST 205.50 -0.32%
SBIN 276.40 -1.16%
More..
NSE INDIA Top Gainers Stocks
AUSTRAL 0.20 33.33%
FCSSOFT 0.25 25.00%
MAHASTEEL 71.70 19.30%
WSI 10.20 18.60%
GINNIFILA 62.40 15.02%
BEPL 58.80 14.51%
NAKODA 0.40 14.29%
SHAKTIPUMP 471.75 12.63%
3IINFOTECH 4.55 12.35%
KSBPUMPS 770.45 12.13%
More..
NSE INDIA Top Losers Stocks
VISESHINFO 0.10 -33.33%
LCCINFOTEC 0.20 -20.00%
NICCO 0.35 -12.50%
SPCENET 0.40 -11.11%
SERVALL 2.80 -11.11%
MVL 0.45 -10.00%
MVL 0.45 -10.00%
KARMAENG 49.70 -9.96%
BLUEBLENDS 55.95 -9.25%
SMPL 1.55 -8.82%
More..

Brooks Laboratories Limited (NSE: BROOKS)

BROOKS Technical Analysis 5
As on 28th Jun 2017 BROOKS Share Price closed @ 102.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 131.27 & Strong Sell for SHORT-TERM with Stoploss of 121.52 we also expect STOCK to react on Following IMPORTANT LEVELS.
BROOKS Target for June
1st Target up-side 132.22
2nd Target up-side 150.04
3rd Target up-side 167.86
1st Target down-side 81.38
2nd Target down-side 63.56
3rd Target down-side 45.74
BROOKS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 30.38 Sideways
MFI (14) MFI is 53.34 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 117.00
10 Day Avg Volume Traded 5.95 % More then 10 Day Average Volume
BROOKS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
BROOKS Address
BROOKS
N/A
BROOKS Latest News
Stocks to Watch: NXP Semi, Hewlett-Packard, Johnson & Johnson   Wall Street Journal (blog)   - 02nd Mar 15
Brooks Labs standalone Dec '14 sales at Rs 23.68 crore   Moneycontrol.com   - 17th Feb 15
Tesco recalls fruit drinks over 'foreign bodies' and 'unusual smell'   Daily Mail   - 28th Jan 15
Sebi slaps Rs 11.80 cr penalty on Brooks Labs and 5 executives   Business Standard   - 12th Jan 15
Brooks Laboratories Ltd clarifies on SEBI order against the firm   Equity Bulls   - 05th Dec 14
Clarification sought from Brooks Laboratories Ltd   Hindu Business Line   - 03rd Dec 14
Sebi passes orders against 8 companies for non-disclosures in IPO   Economic Times   - 02nd Dec 14
Brooks Laboratories appoints SGCO & Co as statutory auditors   Moneycontrol.com   - 12th Aug 14
SEBI imposes Rs. 53.5 cr fine in Brooks Lab IPO case   Hindu Business Line   - 31st Dec 13
IPO Crackdown-2: Brooks Laboratories   Moneylife Personal Finance site and magazine   - 13th Jan 12
Interactive Technical Analysis Chart Brooks Laboratories Limited ( BROOKS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Brooks Laboratories Limited
BROOKS Business Profile
Brooks Labs is in the Pharmaceuticals sector. Brooks Laboratories Ltd. was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups. The current market capitalisation stands at Rs 28.65 crore.The company has reported a standalone sales of Rs 25.20 crore and a Net Profit of Rs 1.9 crore for the quarter ended Sep 2013. The company management includes Atul Ranchal - Chairman, Rajesh Mahajan - Managing Director, D S Maity - Director & CEO, Rajnish Bedi - Independent Director, Bhaskar Sharma - Additional Director. It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS. Its Registered office is at Village Kishanpura, Nalagarh Road,,Baddi Solan District,Himachal Pradesh - 174101.